Dotarem and Swallowing difficulty - a phase IV clinical study of FDA data
Summary:
Swallowing difficulty is found among people who take Dotarem, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Dotarem and have Swallowing difficulty. It is created by eHealthMe based on reports of 2,380 people who have side effects when taking Dotarem from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,380 people reported to have side effects when taking Dotarem.
Among them, 57 people (2.39%) have Swallowing difficulty.
What is Dotarem?
Dotarem has active ingredients of gadoterate meglumine. eHealthMe is studying from 2,380 Dotarem users for its effectiveness, alternative drugs and more.
What is Swallowing difficulty?
Swallowing difficulty is found to be associated with 3,509 drugs and 3,172 conditions by eHealthMe.
Number of Dotarem and Swallowing difficulty reports submitted per year:
Time on Dotarem when people have Swallowing difficulty *:
Gender of people who have Swallowing difficulty when taking Dotarem*:
Age of people who have Swallowing difficulty when taking Dotarem *:
Common drugs people take besides Dotarem *:
Common side effects people have besides Swallowing difficulty *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Dotarem and have Swallowing difficulty?
Check whether Swallowing difficulty is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Swallowing difficulty and when was it recovered:
Expand to all the drugs that have ingredients of gadoterate meglumine:
Alternative drugs to, pros and cons of Dotarem:
- Dotarem (2,380 reports)
Common Dotarem side effects:
- Rashes (redness): 446 reports
- Breathing difficulty: 376 reports
- Itching: 340 reports
- Nausea and vomiting: 304 reports
- Cough: 198 reports
- Dizziness: 166 reports
- Headache (pain in head): 152 reports
- Chest pain: 134 reports
Browse all side effects of Dotarem:
a b c d e f g h i j k l m n o p q r s t u v w x y zSwallowing difficulty treatments and more:
- Swallowing difficulty (98,413 reports)
COVID vaccines that are related to Swallowing difficulty:
- Swallowing difficulty in Moderna COVID Vaccine
- Swallowing difficulty in Pfizer BioNTech Covid Vaccine
- Swallowing difficulty in Johnson and Johnson Covid Vaccine
Common drugs associated with Swallowing difficulty:
- Aspirin: 4,818 reports
- Prednisone: 4,430 reports
- Omeprazole: 3,202 reports
- Lisinopril: 2,813 reports
- Nexium: 2,643 reports
- Synthroid: 2,587 reports
- Fosamax: 2,524 reports
- Gabapentin: 2,402 reports
- Methotrexate: 2,384 reports
- Lipitor: 2,354 reports
All the drugs that are associated with Swallowing difficulty:
- Swallowing difficulty (3,509 drugs)
Common conditions associated with Swallowing difficulty:
- High blood pressure: 4,824 reports
- Multiple sclerosis: 3,962 reports
- Pain: 3,308 reports
- Depression: 2,699 reports
- Parkinson's disease: 2,677 reports
- Osteoporosis: 2,629 reports
All the conditions that are associated with Swallowing difficulty:
- Swallowing difficulty (3,172 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gadoterate meglumine (the active ingredients of Dotarem) and Dotarem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sulindac and Blood Thyroid Stimulating Hormone Increased - 5 seconds ago
- Emla and Dermatillomania - 8 seconds ago
- Duragesic and Nasopharyngitis - 13 seconds ago
- Klonopin vs. Artane - 14 seconds ago
- Potassium Iodide and Brimonidine Tartrate drug interaction - 26 seconds ago
- Ceftriaxone Sodium and Arthritis - 41 seconds ago
- Zelnorm and Angioneurotic Oedema Aggravated - 46 seconds ago
- Cycrin and Stress And Anxiety - 48 seconds ago
- Trulicity and Rhabdomyolysis - 52 seconds ago
- Cytotec and Muscle Contracture - a minute ago